Effects of formulation on the bioavailability of lutein and zeaxanthin: A randomized, double-blind, cross-over, comparative, single-dose study in healthy subjects

European Journal of Nutrition

Volumn 52, Issue 4, 2013, Pages 1381-1391

  Evans, Malkanthi ^a   Beck, Mareike ^b   Elliott, James ^c   Etheve, Stephane ^b   Roberts, Richard ^d   Schalch, Wolfgang ^b  

^a KGK Synergize   (Canada)

^b DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

^c DSM NUTRITIONAL PRODUCTS   (United States)

^d Kemin Industries Inc   (United States)

Author keywords

all E lutein; Bioavailability; Carotenoids; Lutein; Xanthophylls; Zeaxanthin

Indexed keywords

ALGINIC ACID; FLORAGLO; STARCH; UNCLASSIFIED DRUG; XANTHOPHYLL; ZEAXANTHIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; LOOSE FECES; MALE; MAXIMUM PLASMA CONCENTRATION; MORNING DOSAGE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; UNSPECIFIED SIDE EFFECT;

ADULT; ALGINATES; ANTIOXIDANTS; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOOD ADDITIVES; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; KINETICS; LUTEIN; MALE; MIDDLE AGED; NUTRITIVE VALUE; RETINAL PIGMENTS; STARCH; STEREOISOMERISM; XANTHOPHYLLS; YOUNG ADULT;

EID: 84878580426     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-012-0447-9     Document Type: Article

References (28)

1. Bernstein PS, Khachik F, Carvalho LS, Muir GJ, Zhao DY, Katz NB (2001) Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res 72:215-223
2. Burton GW (1989) Antioxidant action of carotenoids. J Nutr 119:109-111
3. Krinsky NI, Landrum JT, Bone RA (2003) Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 23:171-201
4. Johnson EJ, Maras JE, Rasmussen HM, Tucker KL (2010) Intake of lutein and zeaxanthin differ with age, sex, and ethnicity. J Am Diet Assoc 110:1357-1362
5. LeMarchand L, Hankin JH, Bach F, Kolonel LN, Wilkens LR, Stacewicz-Sapuntzakis M, Bowen PE, Beecher GR, Laudon F, Baque P (1995) An ecological study of diet and lung cancer in the South Pacific. Int J Cancer 63:18-23
6. Institute of Medicine (2000) Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academy Press, Washington, DC, pp 332-333
7. Landrum JT, Bone RA, Moore LL, Gomez CM (1999) Analysis of zeaxanthin distribution within individual human retinas. Methods Enzymol 299:457-467
8. Bone RA, Landrum JT, Fernandez L, Tarsis SL (1988) Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci 29:843-849
9. Schalch W (1992) Carotenoids in the retina-a review of their possible role in preventing or limiting damage caused by light and oxygen. In: Emerit I, Chance B (eds) Free radicals and aging. Basel, vol. 62. Switzerland: Birkhauser, EXS, pp 280-298
10. Chiu CJ, Taylor A (2007) Nutritional antioxidants and age-related cataract and maculopathy. Exp Eye Res 84:229-245
11. Kostic D, White WS, Olson JA (1995) Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses. Am J Clin Nutr 62(3):604-610
12. Bowen PE, Herbst-Espinosa SM, Hussain EA, Stacewicz-Sapuntzakis M (2002) Esterification does not impair lutein bioavailability in humans. J Nutr 132(12):3668-3673
13. Norkus EP, Norkus KL, Dharmarajan TS, Schierle J, Schalch W (2010) Serum lutein response is greater from free lutein than from esterified lutein during 4 weeks of supplementation in healthy adults. J Am Coll Nutr 29:575-585
14. Thürmann PA, Schalch W, Aebischer JC, Tenter U, Cohn W (2005) Plasma kinetics of lutein, zeaxanthin, and 3-dehydro-lutein after multiple oral doses of a lutein supplement. Am J Clin Nutr 82:88-97
15. Schalch W, Cohn W, Barker FM, Kõpcke W, Mellerio J, Bird AC, Robson AG, Fitzke FF, van Kuijk FJ (2007) Xanthophyll accumulation in the human retina during supplementation with lutein and zeaxanthin-the LUXEA (LUtein Xanthophyll Eye Accumulation) study. Arch Biochem Biophys 458:128-135
16. Lachin JM (1981) Introduction to sample size determination and power analysis for clinical trials. Controlled Clin Trials 2:93-113
17. Hartmann D, Thürmann PA, Spitzer V, Schalch W, Manner B, Cohn W (2004) Plasma kinetics of zeaxanthin and 3'-dehydro-lutein after multiple oral doses of synthetic zeaxanthin. Am J Clin Nutr 79:410-417
18. Jones B, Kenward MG (2003) Design and analysis of cross-over trials, 2nd edn. Chapman & Hall/CRC, Boca Raton
19. Yao L, Liang Y, Trahanovsky WS, Serfass RE, White WS (2000) Use of a 13C tracer to quantify the plasma appearance of a physiological dose of lutein in humans. Lipids 35:339-348
20. Johnson EJ, Russell RM (1992) Distribution of orally administered beta-carotene among lipoproteins in healthy men. Am J Clin Nutr 56:128-135
21. Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tsipursky M, Nyland J (2004) Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration:the Veternans LAST study (Lutein Antooxidant Supplementation Trial). Optometry 75:216-230
22. Seddon JM, Anjani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT, Yannuzzi LA, Willett W, The Eye Disease Case-Control Study Group (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 272:1413-1420
23. Christen WG, Liu S, Glynn RJ, Gaziano JM, Buring JE (2008) Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study. Arch Ophthalmol 126:102-109
24. Moeller SM, Voland R, Tinker L, Blodi BA, Klein ML, Gehrs KM, Johnson EJ, Snodderly DM, Wallace RB, Chappell RJ, Parekh N, Ritenbaugh C, Mares JA (2008) Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the carotenoids in the age-related eye disease study, an ancillary study of the women's health initiative. Arch Ophthalmol 126:354-364
25. Hammond BR Jr, Johnson EJ, Russell RM, Krinsky NI, Yeum KJ, Edwards RB, Snodderly DM (1997) Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 38:1795-1801
26. Handelman GJ, Nightingale ZD, Lichtenstein AH, Schaefer EJ, Blumberg JB (1999) Lutein and zeaxanthin concentrations in plasma after dietary supplementation with egg yolk. Am J Clin Nutr 70:247-251
27. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564-572
28. Rock CL, Thornquist MD, Neuhouser ML, Kristal AR, Neumark-Sztainer D, Cooper DA, Patterson RE, Cheskin LJ (2002) Diet and lifestyle correlates of lutein in the blood and diet. J Nutr 132:525S-530S